(Q38191876)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24578255%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

review article

1 reference

title

Modes of infection and oncogenesis by the Epstein-Barr virus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24578255%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24578255%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

Hiroshi Kimura

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24578255%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

author name string

Takayuki Murata

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24578255%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

publication date

28 February 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24578255%20AND%20SRC:MED&resulttype=core&format=json

Reviews in Medical Virology

9 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24578255%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24578255%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24578255%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

page(s)

242-253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24578255%20AND%20SRC:MED&resulttype=core&format=json

Epstein-Barr virus: 40 years on

9 March 2020

cites work

1 reference

B cells under influence: transformation of B cells by Epstein–Barr virus

21 January 2018

1 reference

Epstein-Barr virus and oncogenesis: from latent genes to tumours

21 January 2018

1 reference

Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes

21 January 2018

1 reference

LMP1 TRAFficking activates growth and survival pathways

21 January 2018

1 reference

Epstein-Barr virus LMP2A: regulating cellular ubiquitination processes for maintenance of viral latency?

21 January 2018

1 reference

Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression

21 January 2018

1 reference

Induction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines

21 January 2018

1 reference

Role of EBER and BARF1 in nasopharyngeal carcinoma (NPC) tumorigenesis

21 January 2018

1 reference

The role of miRNAs and EBV BARTs in NPC.

21 January 2018

1 reference

The pathological roles of BART miRNAs in nasopharyngeal carcinoma

21 January 2018

1 reference

Epstein-Barr virus (EBV) microRNAs: involvement in cancer pathogenesis and immunopathology

21 January 2018

1 reference

Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients

21 January 2018

1 reference

21 January 2018

1 reference

X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma.

21 January 2018

1 reference

Natural killer T cells and X-linked lymphoproliferative syndrome

21 January 2018

1 reference

Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1.

21 January 2018

1 reference

Stage-specific inhibition of MHC class I presentation by the Epstein-Barr virus BNLF2a protein during virus lytic cycle

21 January 2018

1 reference

Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.

21 January 2018

1 reference

Multiple roles of LMP1 in Epstein-Barr virus induced immune escape.

21 January 2018

1 reference

Epstein-Barr virus: exploiting the immune system

21 January 2018

1 reference

Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma

21 January 2018

1 reference

Inflammation and cancer: how hot is the link?

21 January 2018

1 reference

Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma?

21 January 2018

1 reference

Epstein-Barr virus-associated gastric carcinoma

21 January 2018

1 reference

Host-tumor interactions in nasopharyngeal carcinomas

21 January 2018

1 reference

Large clonal expansions of CD8+ T cells in acute infectious mononucleosis

21 January 2018

1 reference

Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells

21 January 2018

1 reference

Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.

21 January 2018

1 reference

EBV and genomic instability--a new look at the role of the virus in the pathogenesis of Burkitt's lymphoma.

21 January 2018

1 reference

HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis

21 January 2018

1 reference

HLA associations in classical Hodgkin lymphoma: EBV status matters.

21 January 2018

1 reference

HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma

21 January 2018

1 reference

HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma

21 January 2018

1 reference

Human leukocyte antigens related to Epstein-Barr virus-associated gastric carcinoma in Japanese patients

21 January 2018

1 reference

Three Epstein-Barr virus latency proteins independently promote genomic instability by inducing DNA damage, inhibiting DNA repair and inactivating cell cycle checkpoints

21 January 2018

1 reference

Epigenetic dysregulation of the host cell genome in Epstein-Barr virus-associated neoplasia

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphoma

21 January 2018

1 reference

Latent and lytic Epstein-Barr virus replication strategies

21 January 2018

1 reference

T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized mice

21 January 2018

1 reference

Epigenetic regulation of latent Epstein-Barr virus promoters

21 January 2018

1 reference

EBV lytic infection enhances transformation of B-lymphocytes infected with EBV in the presence of T-lymphocytes

21 January 2018

1 reference

AP-1 homolog BZLF1 of Epstein-Barr virus has two essential functions dependent on the epigenetic state of the viral genome

21 January 2018

1 reference

A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas

21 January 2018

1 reference

Epstein-Barr virus BZLF1 gene, a switch from latency to lytic infection, is expressed as an immediate-early gene after primary infection of B lymphocytes

21 January 2018

1 reference

Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification

21 January 2018

1 reference

Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization.

21 January 2018

1 reference

The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome

21 January 2018

1 reference

Methylation-dependent binding of the epstein-barr virus BZLF1 protein to viral promoters

21 January 2018

1 reference

CpG-methylation regulates a class of Epstein-Barr virus promoters

21 January 2018

1 reference

BZLF1 governs CpG-methylated chromatin of Epstein-Barr Virus reversing epigenetic repression

21 January 2018

1 reference

The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

21 January 2018

1 reference

Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency

21 January 2018

1 reference

Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells

21 January 2018

1 reference

Epigenetic control of Epstein-Barr virus transcription - relevance to viral life cycle?

21 January 2018

1 reference

An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions

21 January 2018

1 reference

Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome

21 January 2018

1 reference

The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell

21 January 2018

1 reference

Identification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1.

21 January 2018

1 reference

The Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5

21 January 2018

1 reference

Epstein-Barr virus exploits BSAP/Pax5 to achieve the B-cell specificity of its growth-transforming program

21 January 2018

1 reference

Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors

21 January 2018

1 reference

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

21 January 2018

1 reference

Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells.

21 January 2018

1 reference

Genome guardian p53 and viral infections

21 January 2018

1 reference

Epstein-Barr virus BGLF4 kinase retards cellular S-phase progression and induces chromosomal abnormality

21 January 2018

1 reference

Epstein-Barr virus DNase (BGLF5) induces genomic instability in human epithelial cells

21 January 2018

1 reference

An Epstein-Barr Virus (EBV) mutant with enhanced BZLF1 expression causes lymphomas with abortive lytic EBV infection in a humanized mouse model

21 January 2018

1 reference

Germinal centres: role in B-cell physiology and malignancy

21 January 2018

1 reference

Cytokine mediated induction of the major Epstein-Barr virus (EBV)-encoded transforming protein, LMP-1.

21 January 2018

1 reference

IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines

21 January 2018

1 reference

IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter

21 January 2018

1 reference

The p38 signaling pathway upregulates expression of the Epstein-Barr virus LMP1 oncogene

21 January 2018

1 reference

VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA

21 January 2018

1 reference

Epstein-Barr virus and the somatic hypermutation of immunoglobulin genes in Burkitt's lymphoma cells

21 January 2018

1 reference

Emerging pathways in the development of AIDS-related lymphomas

21 January 2018

1 reference

Documentation of Burkitt lymphoma with t(8;14) (q24;q32) in X-linked lymphoproliferative disease

21 January 2018

1 reference

p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia

21 January 2018

1 reference

Genetic alterations of the retinoblastoma-related gene RB2/p130 identify different pathogenetic mechanisms in and among Burkitt's lymphoma subtypes.

21 January 2018

1 reference

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

21 January 2018

1 reference

Mimicry of CD40 signals by Epstein-Barr virus LMP1 in B lymphocyte responses

21 January 2018

1 reference

Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.

21 January 2018

1 reference

Molecular mechanisms of constitutive NF-kappaB/Rel activation in Hodgkin/Reed-Sternberg cells.

21 January 2018

1 reference

Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma

21 January 2018

1 reference

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

21 January 2018

1 reference

Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.

21 January 2018

1 reference

Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis

21 January 2018

1 reference

Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.

21 January 2018

1 reference

Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations

21 January 2018

1 reference

Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?

21 January 2018

1 reference

Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection

21 January 2018

1 reference

Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.

21 January 2018

1 reference

Quantitative analysis of Epstein-Barr virus (EBV)-specific CD8+ T cells in patients with chronic active EBV infection.

21 January 2018

1 reference

EBV-associated T/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases.

21 January 2018

1 reference

NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm.

21 January 2018

1 reference

The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.

21 January 2018

1 reference

Nasal NK- and T-cell lymphomas share the same type of Epstein-Barr virus latency as nasopharyngeal carcinoma and Hodgkin's disease

21 January 2018

1 reference

Inhibition of latent membrane protein 1 impairs the growth and tumorigenesis of latency II Epstein-Barr virus-transformed T cells.

21 January 2018

1 reference

Concomitant increase of LMP1 and CD25 (IL-2-receptor alpha) expression induced by IL-10 in the EBV-positive NK lines SNK6 and KAI3.

21 January 2018

1 reference

P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan

21 January 2018

1 reference

Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses

21 January 2018

1 reference

Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma

21 January 2018

1 reference

Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches

21 January 2018

1 reference

Epstein-Barr virus in the pathogenesis of NPC.

21 January 2018

1 reference

The significance of LMP1 expression in nasopharyngeal carcinoma

21 January 2018

1 reference

Genetic and epigenetic changes in nasopharyngeal carcinoma.

21 January 2018

1 reference

Nasopharyngeal carcinoma: genetic changes, Epstein-Barr virus infection, or both. A clinical and molecular study of 36 patients.

21 January 2018

1 reference

Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells

21 January 2018

1 reference

Human leukocyte antigens and epstein-barr virus-associated nasopharyngeal carcinoma: old associations offer new clues into the role of immunity in infection-associated cancers.

21 January 2018

1 reference

Epstein-Barr Virus (EBV)-associated gastric carcinoma

21 January 2018

1 reference

A naturally derived gastric cancer cell line shows latency I Epstein-Barr virus infection closely resembling EBV-associated gastric cancer

21 January 2018

1 reference

Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer

21 January 2018

1 reference

Epstein-Barr virus infection as an epigenetic driver of tumorigenesis

21 January 2018

1 reference

Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/RMV.1786

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24578255%20AND%20SRC:MED&resulttype=core&format=json

9 March 2020

1 reference